Oncosec Medical (ONCS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ONCS | AMGN | GILD | CELG | BIIB |
| Company | Oncosec Medical | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.3529 | 273.45 | 67.47 | 108.01 | 201.21 |
| High | 0.3972 | 274.35 | 67.90 | 108.59 | 205.36 |
| Low | 0.2520 | 267.24 | 65.26 | 107.27 | 198.11 |
| Last | 0.2772 | 270.01 | 65.45 | 108.24 | 201.87 |
| Change | +0.0670 | -3.00 | -1.63 | +0.11 | -0.12 |
| % Change | +31.87% | -1.10% | -2.43% | +0.10% | -0.06% |
| Volume | 52,491,000 | 747,588 | 5,988,846 | 191,230,496 | 883,975 |
| 20-Day Average Volume | 4,069,205 | 2,095,505 | 6,374,244 | 16,188,930 | 1,243,398 |
| Previous Close | 0.2102 | 273.01 | 67.08 | 108.13 | 201.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3732 | 270.68 | 68.70 | 108.17 | 201.36 |
| 20-Day Raw Stochastic | 30.50% | 29.91% | 2.92% | 63.25% | 39.23% |
| 20-Day Relative Strength | 32.70% | 44.49% | 29.01% | 64.69% | 41.48% |
| Weighted Alpha | -93.96 | +8.92 | -23.24 | +46.30 | -35.35 |
| Today's Opinion | 100% Sell | 72% Sell | 100% Sell | 100% Buy | 100% Sell |
| Previous Opinion | 100% Sell | 40% Sell | 100% Sell | 100% Buy | 100% Sell |
| Last Month's Opinion | 100% Sell | 24% Buy | 88% Sell | 100% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +28.16% since 06/15/23 | +2.39% since 04/18/24 | -0.89% since 04/18/24 | -1.97% since 11/13/19 | +5.23% since 04/18/24 |
| Low | 0.1800 on 06/22/23 | 260.68 on 04/19/24 | 65.32 on 04/25/24 | 107.27 on 11/20/19 | 189.44 on 04/19/24 |
| High | 0.3972 on 06/23/23 | 274.86 on 04/24/24 | 67.78 on 04/25/24 | 110.53 on 11/14/19 | 205.75 on 04/24/24 |
| 1-Month | |||||
| %Chg | -45.66% since 05/23/23 | -4.20% since 03/25/24 | -9.66% since 03/25/24 | +5.14% since 10/18/19 | -7.48% since 03/25/24 |
| Low | 0.1800 on 06/22/23 | 260.68 on 04/19/24 | 65.32 on 04/25/24 | 102.40 on 10/21/19 | 189.44 on 04/19/24 |
| High | 0.5100 on 05/24/23 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 217.57 on 03/28/24 |
| 3-Month | |||||
| %Chg | -87.57% since 03/23/23 | -13.29% since 01/25/24 | -18.27% since 01/25/24 | +13.63% since 08/20/19 | -18.58% since 01/25/24 |
| Low | 0.1800 on 06/22/23 | 260.68 on 04/19/24 | 65.32 on 04/25/24 | 93.41 on 08/23/19 | 189.44 on 04/19/24 |
| High | 3.2900 on 03/27/23 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 110.70 on 11/13/19 | 251.99 on 01/31/24 |
| 6-Month | |||||
| %Chg | -84.07% since 12/23/22 | -1.15% since 10/25/23 | -16.35% since 10/25/23 | +14.14% since 05/20/19 | -18.74% since 10/25/23 |
| Low | 0.1800 on 06/22/23 | 249.70 on 10/31/23 | 65.32 on 04/25/24 | 89.08 on 07/23/19 | 189.44 on 04/19/24 |
| High | 3.4900 on 03/14/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,262 | 146,436,016 | 83,519,768 | 77,035,920 | 29,361,468 |
| Shares Outstanding, K | 4,554 | 536,376 | 1,245,077 | 711,714 | 145,361 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,835,600,000 |
| Annual Net Income | -34,180,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 1,161,100,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,386,300,000 |
| Last Quarter Net Income | -6,860,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 249,700,000 |
| 60-Month Beta | 1.99 | 0.58 | 0.19 | 1.41 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.65 on 03/13/23 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 3.67 on 04/24/24 |
| Latest Earnings Date | 06/27/23 | 05/02/24 | 04/25/24 | 10/31/19 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.67 | 9.97 | 10.99 | 13.11 |